Sientra (NASDAQ:SIEN – Get Rating) had its price target trimmed by Craig Hallum to $2.00 in a research note issued to investors on Monday, Stock Target Advisor reports.

Other analysts have also recently issued reports about the company. Canaccord Genuity Group dropped their target price on Sientra from $8.00 to $5.00 in a report on Friday, May 13th. StockNews.com cut Sientra from a hold rating to a sell rating in a report on Tuesday, May 10th. Finally, Maxim Group reiterated a buy rating and set a $5.00 price target on shares of Sientra in a report on Friday, May 13th. One investment analyst has rated the stock with a sell rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $6.63.

Get Sientra alerts:

Sientra Stock Up 13.0 %

Shares of NASDAQ:SIEN opened at $1.11 on Monday. The company has a quick ratio of 0.77, a current ratio of 1.40 and a debt-to-equity ratio of 7.28. The business has a fifty day moving average of $0.95 and a two-hundred day moving average of $1.68. The stock has a market cap of $69.53 million, a P/E ratio of -1.19 and a beta of 1.95. Sientra has a 52-week low of $0.70 and a 52-week high of $6.72.

Hedge Funds Weigh In On Sientra

Hedge funds and other institutional investors have recently bought and sold shares of the company. Advisor Group Holdings Inc. boosted its holdings in Sientra by 230.9% during the 1st quarter. Advisor Group Holdings Inc. now owns 11,930 shares of the medical instruments supplier's stock valued at $26,000 after acquiring an additional 8,325 shares during the period. Mirabella Financial Services LLP purchased a new position in Sientra during the 1st quarter valued at about $26,000. Stephens Inc. AR boosted its holdings in Sientra by 48.1% during the 2nd quarter. Stephens Inc. AR now owns 50,775 shares of the medical instruments supplier's stock valued at $43,000 after acquiring an additional 16,500 shares during the period. ProShare Advisors LLC purchased a new position in Sientra during the 4th quarter valued at about $47,000. Finally, Paradigm Financial Partners LLC purchased a new position in Sientra during the 4th quarter valued at about $50,000. 82.42% of the stock is currently owned by hedge funds and other institutional investors.

Sientra Company Profile

(Get Rating)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Stories

• Get a free copy of the StockNews.com research report on Sientra (SIEN)
• 3 Blowout Earnings Reports That Could Mark Turning Points
• Skyworks Solutions Is Worth A Look At These Prices
• Will CrowdStrike Extend Its Streak Of Topping Earnings Views?
• 3 Stocks Set to Lead the Nasdaq Bull Market
• MarketBeat Podcast: ESG – Profitably Invest Your Values

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.